Respond to this discussion post in 5- 7 sentences in a positive way The FDA’s Response to the COVID-19 pandemic was impo
Posted: Tue Feb 15, 2022 3:49 pm
Respond to this discussion post in 5- 7 sentences in a positive
way
The FDA’s Response to the COVID-19 pandemic was important to the
FDA, industry, clinicians, and patients. At the beginning of the
pandemic, there were concerns of having adequate testing for
COVID-19 and personal protective equipment (PPE) for the public and
healthcare workers. This pandemic could have been far worse if the
FDA did not respond in the way they did. Due to the novelty of this
virus, testing did not exist prior to the pandemic. The FDA’s
allowance for Emergency Use Authorization during this public health
emergency for in vitro diagnostic testing kits, testing supplies,
and other medical devices such as, ventilators, was absolutely
necessary to tackle the pandemic. Ultimately, the goal was and
still is to avoid spreading this virus. Adequate availability of
testing and supplies are necessary to combat this virus and slow
the spread. If infected individuals are identified through testing
and proper PPE is available, this could mitigate the spread of this
virus. The FDA also reached out to other government agencies,
medical device developers, and international regulatory agencies to
ensure sufficient medical devices, testing kits, and supplies were
available. The FDA addressed supply change issues by allocating a
substantial amount of money in their budget to the Resilient Supply
Chain and Shortages Prevention Program (RSCSPP). They also took
several actions to identify the shortages, discuss with
manufacturers and distributors, and repurposing employees to help
overcome the shortages. Without the actions the FDA took during the
COVID-19 pandemic, the U.S. would have been in a far worse public
health crisis. Testing for COVID-19 would not have been available
as quickly as it had been and the public and especially, healthcare
workers, would not have had the PPE and supplies need to protect
themselves and safely treat patients infected with COVID-19.
way
The FDA’s Response to the COVID-19 pandemic was important to the
FDA, industry, clinicians, and patients. At the beginning of the
pandemic, there were concerns of having adequate testing for
COVID-19 and personal protective equipment (PPE) for the public and
healthcare workers. This pandemic could have been far worse if the
FDA did not respond in the way they did. Due to the novelty of this
virus, testing did not exist prior to the pandemic. The FDA’s
allowance for Emergency Use Authorization during this public health
emergency for in vitro diagnostic testing kits, testing supplies,
and other medical devices such as, ventilators, was absolutely
necessary to tackle the pandemic. Ultimately, the goal was and
still is to avoid spreading this virus. Adequate availability of
testing and supplies are necessary to combat this virus and slow
the spread. If infected individuals are identified through testing
and proper PPE is available, this could mitigate the spread of this
virus. The FDA also reached out to other government agencies,
medical device developers, and international regulatory agencies to
ensure sufficient medical devices, testing kits, and supplies were
available. The FDA addressed supply change issues by allocating a
substantial amount of money in their budget to the Resilient Supply
Chain and Shortages Prevention Program (RSCSPP). They also took
several actions to identify the shortages, discuss with
manufacturers and distributors, and repurposing employees to help
overcome the shortages. Without the actions the FDA took during the
COVID-19 pandemic, the U.S. would have been in a far worse public
health crisis. Testing for COVID-19 would not have been available
as quickly as it had been and the public and especially, healthcare
workers, would not have had the PPE and supplies need to protect
themselves and safely treat patients infected with COVID-19.